LOS
ANGELES, March 10, 2025 /PRNewswire/ -- The
DJS Law Group reminds investors of a class action lawsuit
against BioAge Labs, Inc. ("BioAge" or "the Company") (NASDAQ:
BIOA) for violations of the federal securities laws.
Shareholders who purchased the Company's securities pursuant
and/or traceable to the Company's initial public offering ("IPO")
conducted on September 26, 2024, are
encouraged to contact the firm before March
10, 2025.
CASE DETAILS: According to the Complaint,
BioAge allegedly made false and misleading statements
to the market when it announced on December
6, 2024, that it would discontinue its ongoing STRIDES Phase
2 trial of its lead trial candidate, azelaprag. The Company cited
safety concerns in participants as the reason for the
discontinuation, contrary to its claims during the IPO that
azelaprag had potential in patients in obesity therapy with
incretin drugs.
If you are a shareholder who suffered a loss, contact us to
participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is
to enhance investor return through balanced counseling and
aggressive advocacy. We specialize in securities class actions,
corporate governance litigation, and domestic/international M&A
appraisals. Our clients are some of the largest and most
sophisticated hedge funds and alternative asset managers in the
world. The litigation claims of our clients are extraordinarily
valuable assets that demand respect, focus, and results.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
CONTACT:
David J.
Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/final-deadline-for-the-bioage-labs-inc-securities-lawsuit---contact-the-djs-law-group-to-discuss-your-rights---bioa-302396627.html
SOURCE DJS Law Group LLP
